CA2588940C - Lactobacilles de liaison par les groupes sanguins humains a, b et o - Google Patents
Lactobacilles de liaison par les groupes sanguins humains a, b et o Download PDFInfo
- Publication number
- CA2588940C CA2588940C CA2588940A CA2588940A CA2588940C CA 2588940 C CA2588940 C CA 2588940C CA 2588940 A CA2588940 A CA 2588940A CA 2588940 A CA2588940 A CA 2588940A CA 2588940 C CA2588940 C CA 2588940C
- Authority
- CA
- Canada
- Prior art keywords
- blood group
- lactobacilli
- antigen
- ability
- lactobacillus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/127—Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Virology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- General Engineering & Computer Science (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Les bactéries de l'acide lactique sont criblées par spectroscopie par résonance plasmonique de surface, la mucine intestinale humaine et des antigènes des types sanguins étant utilisés en tant que sondes. Afin de s'adapter à un criblage de grande échelle, on s'efforce de définir des normes de sélection pour le criblage des bactéries de l'acide lactique tel que décrit ci-dessus. Il s'avère par conséquent que les bactéries de l'acide lactique correspondant respectivement aux types sanguins ABO peuvent être criblées au moyen de 100RU à des conditions spécifiques en tant que norme de liaison des bactéries. 238 souches de bactéries de l'acide lactique sont soumises à ce criblage. Ensuite, un test destiné à déterminer l'aptitude à la production de yaourt est réalisé. Enfin, les souches correspondant aux types sanguins individuels A, B et O sont clarifiées en pratique.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004349135 | 2004-12-01 | ||
| JP2004-349135 | 2004-12-01 | ||
| JPPCT/JP2005/011043 | 2005-06-16 | ||
| PCT/JP2005/011043 WO2006059408A1 (fr) | 2004-12-01 | 2005-06-16 | Bactérie lactique se liant aux groupes sanguins abo humains |
| PCT/JP2005/022096 WO2006067940A1 (fr) | 2004-12-01 | 2005-12-01 | Bacteries de l’ acide lactique se liant a des types sanguins abo humains |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2588940A1 CA2588940A1 (fr) | 2006-06-29 |
| CA2588940C true CA2588940C (fr) | 2015-10-13 |
Family
ID=36601545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2588940A Expired - Fee Related CA2588940C (fr) | 2004-12-01 | 2005-12-01 | Lactobacilles de liaison par les groupes sanguins humains a, b et o |
Country Status (2)
| Country | Link |
|---|---|
| CA (1) | CA2588940C (fr) |
| WO (1) | WO2006067940A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5266596B2 (ja) * | 2006-12-28 | 2013-08-21 | グリコ乳業株式会社 | 免疫賦活作用を有する乳酸菌,免疫賦活作用を有する製品及びその製造方法 |
| EP2476747B1 (fr) | 2007-11-29 | 2014-09-03 | Meiji Co., Ltd | Bactéries d'acide lactique ayant une action de réduction du niveau d'acide urique dans le sang |
| EP2221360B1 (fr) * | 2007-11-30 | 2014-03-05 | Meiji Co., Ltd. | Bactérie de l'acide lactique ayant l'effet d'abaisser le niveau sanguin d'acide urique |
| JP6230050B2 (ja) * | 2013-10-09 | 2017-11-15 | 国立研究開発法人農業・食品産業技術総合研究機構 | 消化管粘膜付着性を有する乳酸菌 |
| AU2017327485B2 (en) | 2016-09-16 | 2023-10-19 | International N&H Denmark Aps | Bacteria |
| JP2023179810A (ja) * | 2020-11-13 | 2023-12-20 | 味の素株式会社 | ラクトコッカス・ラクチス、ラクトバチルス属に属する微生物、又はこれらの混合微生物を含有する生菌剤及びその製造方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3919635B2 (ja) * | 2002-09-05 | 2007-05-30 | 明治乳業株式会社 | プロバイオティクス乳酸菌のスクリーニング方法 |
-
2005
- 2005-12-01 CA CA2588940A patent/CA2588940C/fr not_active Expired - Fee Related
- 2005-12-01 WO PCT/JP2005/022096 patent/WO2006067940A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2588940A1 (fr) | 2006-06-29 |
| WO2006067940A1 (fr) | 2006-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8465933B2 (en) | Method for screening human ABO blood group-binding lactobacilli | |
| Uchida et al. | Lactobacilli binding human A-antigen expressed in intestinal mucosa | |
| Schillinger et al. | In vitro adherence and other properties of lactobacilli used in probiotic yoghurt-like products | |
| TWI383049B (zh) | Improved lactose intolerance of lactic acid bacteria | |
| Del Re et al. | Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum | |
| JP3695648B2 (ja) | 抗高血圧性ジペプチドおよびトリペプチドを産生するLactobacillus helveticus | |
| Muñoz-Provencio et al. | Adhesion properties of Lactobacillus casei strains to resected intestinal fragments and components of the extracellular matrix | |
| Uchida et al. | A new assay using surface plasmon resonance (SPR) to determine binding of the Lactobacillus acidophilus group to human colonic mucin | |
| Zhang et al. | First insight into the probiotic properties of ten Streptococcus thermophilus strains based on in vitro conditions | |
| CA3179561A1 (fr) | Composition pour ameliorer le microbiote intestinal | |
| JP2019531720A (ja) | 細菌 | |
| CA2588940C (fr) | Lactobacilles de liaison par les groupes sanguins humains a, b et o | |
| Kocabay | Evaluation of probiotic properties of Levilactobacillus brevis isolated from hawthorn vinegar | |
| JP7809469B2 (ja) | 菌体外多糖の検出方法 | |
| JP2024009616A (ja) | Gpr120作動用組成物 | |
| Champiri et al. | Isolation and Identification of Lactobacillus brevis from Local Cheese of Bazoft and Evaluation of Antimicrobial Activity Against Some Pathogenic Microorganisms. | |
| JP2008179630A (ja) | 免疫賦活作用を有する乳酸菌,免疫賦活作用を有する製品及びその製造方法。 | |
| Benameur et al. | Isolation of 60 strains from fermented milk of mares and donkeys in Algeria and identification by 16S rRNA sequencing of lactobacilli: Assessment of probiotic skills of important strains and aromatic productivity power | |
| JP3919635B2 (ja) | プロバイオティクス乳酸菌のスクリーニング方法 | |
| WO2022220154A1 (fr) | Procédé de détection d'exopolysaccharide | |
| Bae et al. | Probiotic Characterization of Acid-and Bile-tolerant Lactobacillus salivarius subsp. salivarius from Korean Faeces | |
| JP3901291B2 (ja) | モノクローナル抗体、抗体感作コロイド金及び抗体感作コロイド金を用いた抗原の検出方法 | |
| Abbas et al. | Determination of antimicrobial, pH, bile salt, and gastric juice tolerance properties of Lactobacilli isolated from human milk | |
| Mohammed | Assessment of Lactic Acid Bacteria Isolated from White Cheese (Gibna Bayda) Produced in El Dueim City, White Nile State-Sudan | |
| Jyotsna et al. | Exopolysaccharide production and cholesterol reduction by lactic acid bacteria isolated from traditionally fermented Indian foods. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20210831 |
|
| MKLA | Lapsed |
Effective date: 20191202 |